These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 3872056
1. Electrophysiologic and antiarrhythmic properties of bepridil. Prystowsky EN. Am J Cardiol; 1985 Mar 15; 55(7):59C-62C. PubMed ID: 3872056 [Abstract] [Full Text] [Related]
2. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia. Rowland E, McKenna WJ, Krikler DM. Am J Cardiol; 1985 Jun 01; 55(13 Pt 1):1513-9. PubMed ID: 3873867 [Abstract] [Full Text] [Related]
3. Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil. Singh BN, Nademanee K, Feld G, Piontek M, Schwab M. Am J Cardiol; 1985 Mar 15; 55(7):14C-19C. PubMed ID: 3872052 [Abstract] [Full Text] [Related]
4. Prolongation of QT interval and antiarrhythmic action of bepridil. Somberg J, Torres V, Flowers D, Miura D, Butler B, Gottlieb S. Am Heart J; 1985 Jan 15; 109(1):19-27. PubMed ID: 3871296 [Abstract] [Full Text] [Related]
5. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog. Keren G, Tepper D, Butler B, Torres V, Somberg JC. Am Heart J; 1984 Nov 15; 108(5):1236-43. PubMed ID: 6333809 [Abstract] [Full Text] [Related]
10. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias. Sung RJ, Juma Z, Saksena S. Am Heart J; 1983 May 15; 105(5):811-9. PubMed ID: 6189384 [Abstract] [Full Text] [Related]
11. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil]. Fauchier JP, Cosnay P, Néel C, Rouesnel P, Bonnet P, Quilliet L. Arch Mal Coeur Vaiss; 1985 Apr 15; 78(4):612-9. PubMed ID: 3923987 [Abstract] [Full Text] [Related]
12. Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents. Gomes JA, Hariman RJ, Kang PS, Chowdry IH. J Am Coll Cardiol; 1985 Jan 15; 5(1):45-57. PubMed ID: 3964808 [Abstract] [Full Text] [Related]
13. Use of calcium channel entry blockers in the treatment of cardiac arrhythmias. Akhtar M, Tchou P, Jazayeri M. Circulation; 1989 Dec 15; 80(6 Suppl):IV31-9. PubMed ID: 2688983 [Abstract] [Full Text] [Related]
14. [Oral and intravenous bepridil in the treatment of recurrent sustained ventricular tachycardias. Electropharmacological study]. Lévy S, Metge M, Cointe R, Labrunie P, Valeix P, Gérard R. Arch Mal Coeur Vaiss; 1985 Oct 15; 78 Spec No():63-6. PubMed ID: 3938261 [Abstract] [Full Text] [Related]
15. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M. Indian Heart J; 1996 Oct 15; 48(2):133-7. PubMed ID: 8682552 [Abstract] [Full Text] [Related]
16. Electrophysiologic and antiarrhythmic effects of carocainide in humans. Bach P, Steinbeck G. J Cardiovasc Pharmacol; 1988 Dec 15; 12(6):637-42. PubMed ID: 2467080 [Abstract] [Full Text] [Related]
17. Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics. Ohe T, Shimomura K, Aihara N, Kamakura S, Matsuhisa M, Sato I, Nakagawa H, Shimizu A. Circulation; 1988 Mar 15; 77(3):560-8. PubMed ID: 3342487 [Abstract] [Full Text] [Related]
20. Electrophysiologic effects and long-term efficacy of bepridil for recurrent supraventricular tachycardias. Roy D, Montigny M, Klein GJ, Sharma AD, Cassidy D. Am J Cardiol; 1987 Jan 01; 59(1):89-92. PubMed ID: 3492906 [Abstract] [Full Text] [Related] Page: [Next] [New Search]